Of the eight globally listed exchange traded products that track the Nasdaq Biotechnology Index (the gold standard of biotech indexes), this newly minted ETF is a practical option for investors – and the least expensive. Here’s how the fund is setting itself apart. CLICK HERE.
This Biotech ETF Is New, Practical & Cost-Effective
- by Ashley Hayes